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Human  exposure  to  endocrine  disruptors  is  well  documented  by  biomonitoring  data.  However,  this
information  is  limited  to  few  chemicals  like  bisphenol  A  or phthalate  plasticizers.  To  account  for  so-far
unidentiﬁed  endocrine  disruptors  and  potential  mixture  effects  we  employ  bioassays  to  detect  endocrine
activity  in  foodstuff  and  consequently  characterize  the  integrated  exposure  to  endocrine  active  com-
pounds.
Recently,  we reported  a broad  contamination  of commercially  available  bottled  water  with  estro-
genic  activity  and  presented  evidence  for  the  plastic  packaging  being  a source  of  this  contamination.  In
continuation  of that  work,  we  here  compare  different  sample  preparation  methods  to extract  estrogen-
like  compounds  from  bottled  water.  These  data  demonstrate  that  inappropriate  extraction  methods  and
sample  treatment  may  lead  to false-negative  results  when  testing  water  extracts  in  bioassays.
Using  an  optimized  sample  preparation  strategy,  we  furthermore  present  data  on the  estrogenic  activity
of  bottled  water  from  France,  Germany,  and  Italy:  eleven  of  the  18  analyzed  water  samples  (61.1%) induced
a  signiﬁcant  estrogenic  response  in  a bioassay  employing  a  human  carcinoma  cell  line  (MCF7,  E-Screen).
The  relative  proliferative  effects  ranged  from  19.8  to 50.2%  corresponding  to  an  estrogenic  activity  of
1.9–12.2  pg  estradiol  equivalents  per  liter  bottled  water.
When comparing  water  of  the  same  spring  that  is  packed  in  glass  or  plastic  bottles  made  of  polyethy-
lene  terephthalate  (PET),  estrogenic  activity  is  three  times  higher  in water  from  plastic  bottles.  These
data  support  the  hypothesis  that  PET  packaging  materials  are  a source  of estrogen-like  compounds.  Fur-
thermore,  the  ﬁndings  presented  here  conform  to  previous  studies  and  indicate  that  the  contamination
of  bottled  water  with  endocrine  disruptors  is  a transnational  phenomenon.. Introduction
In 1991 scientists from diverse disciplines gathered at the
ingspread Conference Center to structure and deﬁne the phe-
omenon of endocrine disruption. They came to the consensus that
a large number of man-made chemicals [. . .]  have the potential
o disrupt the endocrine system of animals, including humans”
1]. Since then, research in this multidisciplinary ﬁeld and thus
nowledge about endocrine disruptors is steadily expanding. Many
urrent aspects concerning the effects of endocrine disruptors on
Abbreviations: b.d.l., below detection limit; DMEM,  Dulbecco’s modiﬁed
agle’s  medium; DMSO, dimethyl sulfoxide; EEQ, estradiol equivalents; HEPES,
-(2-hydroxyethyl)-1-piperazineethanesulfonic acid; MCF7, Michigan Cancer Foun-
ation cell line 7; PET, polyethylene terephthalate; PTFE, polytetraﬂuoroethylene;
PE,  relative proliferative effect; SPE, solid phase extraction; YES, Yeast Estrogen
creen.
 Article  submitted for the special issue on Endocrine disruptors.
∗ Corresponding author. Tel.: +49 69 798 24900; fax: +49 69 798 24748.
E-mail  address: wagner@bio.uni-frankfurt.de (M.  Wagner).
960-0760©  2010 Elsevier Ltd. 
oi:10.1016/j.jsbmb.2010.10.007
Open access under CC BY-NC-ND license.© 2010 Elsevier Ltd. 
different hormonal pathways [Kato, this issue; Watson, this issue;
vom Saal, this issue; Baker, this issue; Blumberg, this issue], organs
[Prins, this issue; Miyagawa, this issue], individuals [Rubin, this
issue], and populations [Woodruff, this issue; Hayes, this issue] are
comprehensively documented in this Special Issue of The Journal
of Steroid Biochemistry and Molecular Biology.
Characterizing the exposure to endocrine disruptors has been
recognized as a crucial aspect for the prediction of actual health
effects in the Wingspread Consensus [1]. Two  decades later, the
Endocrine Society renewed the demand for making the screen-
ing for exposures a research priority in its Scientiﬁc Statement on
endocrine disruptors [2]. However, understanding the complexity
of human exposure to man-made chemicals, including endocrine
disruptors, is compromised by the overwhelming number of com-
pounds in use and the technical limitations in their detection. Thus,
exposure science is forced to focus on few chemicals as proxies for
Open access under CC BY-NC-ND license.the total exposure, like for example bisphenol A and phthalates for
which excellent biomonitoring data are available [3,4]. Whether
these compounds adequately represent the total exposure and con-
sequently the total toxicity remains, nevertheless, questionable in
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ace of a “universe of toxicants” as Daughton phrases it [5]. In this
espect, recent advances in mixture toxicity contribute to a more
olistic appraisal of the effect assessment in toxicology [6–8]. For
xposure assessment on the other hand, that same holistic view is
esirable but obstructed by the limitation of analytical tools to elu-
idate the entire chemical universe including an unknown number
f yet-to-be identiﬁed compounds.
Bioanalytical techniques (i.e. bioassays) can help to overcome
his shortcoming because they characterize the actual biologi-
al effect of a complex sample and thus integrate the effects of
nidentiﬁed compounds and potential mixtures. Ecotoxicology
akes advantage of that by routinely employing in vitro bioassays to
ssess the endocrine activity in environmental samples (e.g. efﬂu-
nts from sewage treatment). In human toxicology this practice is
ar less common, and only scarce data is available for endocrine
ctivity of human matrices [9–13] or foodstuff as main route of
xposure [14–16].
In  this context, we focus on bottled mineral water and char-
cterize its total estrogenic burden using bioassays. Since limited
n vitro evidence for the presence of estrogen-like chemicals in bot-
led water is available [17–19], the present study aims to provide
dditional data on that issue. In our previous study, we  employed
 yeast-based bioassay (Yeast Estrogen Screen, YES) to deter-
ine the estrogenicity of bottled water. Therefore, we  decided to
eassess our ﬁndings using an additional bioassay that is based on a
uman cancer cell line (MCF7, E-Screen). Developing and employ-
ng an optimized sample preparation method, we  here report a
road contamination of commercially available bottled water with
strogen-like compounds. When comparing water from the same
pring that was packed in glass or plastic bottles, estrogenicity was
igniﬁcantly higher in samples from PET bottles. This corroborates
ur hypothesis that the plastic packaging is one source of so-far
nidentiﬁed endocrine disruptors in bottled water.
.  Materials and methods
.1.  Samples
Bottled mineral water was purchased at local retailer stores. In
otal, the analyzed water samples comprised 18 products (coded as
amples 1 to 18) from 13 different companies, including water from
ve bottlers that was packed in glass and plastic bottles made of PET
samples 1 + 2, 3 + 4, 5 + 6, 7 + 8, 9 + 10). With the exception of one
o-called table water (bottled tap water), the products are marketed
s so-called mineral water. These products originate from natural
prings and are not processed or altered beyond deferrization. The
prings of the products are located in different geographic regions
n France, Germany, and Italy. Of each product, a sufﬁcient number
f bottles from the same lot (n = 10–12) was purchased and stored
t 4 ◦C prior to analysis.
.2.  Optimization strategy for sample preparation
Sample preparation methods, like the extraction of water sam-
les by solid phase extraction (SPE), are normally optimized for
he analytical detection of speciﬁc chemicals. In case of bioassays,
hat also include effects of unknown compounds and mixtures, an
daptation of those methods is needed. Here, we  apply a tiered
pproach to develop an optimized sample preparation procedure
y comparing different methods of (1) sample treatment and (2)
olid phase extraction and (3) apply the optimized procedure to broader range of samples. The ﬁrst two steps were carried out
ith tap water as procedural blank and one bottled water (sample
8) that has been repeatedly shown to be estrogenic in previous
xperiments.istry & Molecular Biology 127 (2011) 128– 135 129
2.3. Sample treatment
Evaporation of sample extracts is a common procedure to reduce
the extract volume or exchange a solvent. In in vitro bioassays
extracts are often evaporated directly on the microtiter plates to
eliminate a particular solvent. To investigate whether evaporation
of extracts during sample preparation results in a loss of estrogenic
activity, we extracted tap water and bottled water (sample 18) via
SPE using reversed phase C18 columns (C18-HD, 24 mg,  3 M,  St.
Paul, MN). The SPE columns were conditioned twice with 4 mL  ace-
tone and equilibrated twice with 4 mL  tap water. 1.5 L water sample
was loaded on each column using a vacuum manifold and a max-
imum ﬂow rate of 12 mL/min. One set of columns containing tap
water or bottled water was dried under a gentle stream of nitrogen
for 30 min. After that, these columns were eluted with 4 mL  ace-
tone, and extracts were evaporated to dryness under nitrogen and
redissolved in 100 L dimethyl sulfoxide (DMSO, method A). From
the second set of columns residual water was  removed by apply-
ing vacuum for 1 min  (method B). Compared to method A, 100 L
DMSO was  added to the extracts before evaporation. Due to its high
melting point DMSO functions as a so-called keeper that retains
volatile compounds during evaporation [20]. Again, nitrogen was
used to remove acetone yielding residual extracts in 100 L DMSO.
All extracts were stored in glass vials with PTFE caps at −20 ◦C prior
to analysis in the E-Screen.
2.4.  Comparison of different solid phase extraction methods
In  the next step of optimization six different SPE sorbents
were compared. In addition to the silica phase (C18) described
above, copolymer sorbents were used because of their higher
capacity and selectivity for polar compounds. These SPE sor-
bents include the copolymers N-vinylpyrrolidone-divinylbenzene
(Oasis  HLB, 200 mg,  Waters, Milford, MA) as well as styrene-
divinylbenzene (Bakerbond SDB1, 200 mg,  J.T. Baker, Deventer,
Netherlands; SDBXC, 15 mg,  3 M,  St. Paul, MN)  and its hydroxy-
lated form (Isolute ENV+, 200 mg,  Biotage, Uppsala, Sweden). The
sixth sorbent consists of an amorphous carbon molecular sieve
(ENVI-Carb Plus, 400 mg,  Supelco, Bellefonte, PA) that is optimal
for the enrichment of highly polar compounds from water sam-
ples.
The general procedure for solid phase extraction of tap and
bottled water was performed with the six different sorbents as
described above. Each sorbent was conditioned according to the
manufacturer’s recommendation: C18 (2 × 4 mL acetone, 2 × 4 mL
tap water), HLB/ENV+/SDB1/Carb (2 × 4 mL  methanol, 2 × 4 mL  tap
water), and SDBXC (4 mL 1:1 ethyl acetate:methylene chloride,
2 × 4 mL  methanol, 2 × 4 mL  tap water). 1.5 L tap water or bottled
water was  applied to each column. In case of bottled water (sam-
ple 18) the content of twelve individual bottles was mixed in equal
parts to create one uniform sample for all extraction procedures.
Columns were shortly dried under vacuum and eluted with 4 mL
acetone (C18) or 4 mL  methanol (all other sorbents). The resulting
sample extracts (containing 100 L DMSO as keeper) were concen-
trated under nitrogen and kept in glass vials with PTFE caps (−20 ◦C)
prior to analysis in the E-Screen.
2.5.  Optimized sample preparation procedure
Based of the previous experiments, an optimized method was
used to extract a broader spectrum of bottled water. 1.5 L of 18 dif-
ferent products were degassed in an ultrasonic bath. C18 columns
were conditioned with 2 × 4 mL  acetone and 2 × 4 mL tap water.
Water samples were drawn through the columns with a ﬂow
rate of 12 mL/min and directly eluted with 4 mL  acetone and 4 mL
methanol consecutively in glass vials containing 50 L DMSO. Ace-
1 chemistry & Molecular Biology 127 (2011) 128– 135
t
y
2
i
r
p
h
D
a
m
f
p
w
t
a
t
u
t
m
m
(
c
p
m
o
p
s
a
w
2
p
S
r
u
o
m
s
e
t
p
o
ﬁ
R
t
w
c
1
a
t
s
o
3
e
(
K
w
c
u
Fig. 1. Effect of sample evaporation on the estrogenic activity of tap and bot-
tled  water. The estrogenicity in the E-Screen is signiﬁcantly higher in bottled30 M.  Wagner, J. Oehlmann / Journal of Steroid Bio
one and methanol was removed under a gentle stream of nitrogen
ielding ﬁnal extracts in 50 L DMSO.
.6. E-Screen
In  the E-Screen, estrogen-dependent proliferation of MCF7 cells
s used to assess the estrogenic potential of chemicals and envi-
onmental samples [21,22]. The cell culture conditions and assay
rocedure have been described previously [20,23] and are used
ere with minor modiﬁcations. In brief, MCF7 cells (a kind gift by
r. A. Soto, Boston, MA)  were seeded on 96-well microtiter plates
t an initial density of 1500 cells/well. Hormone-free cell culture
edium (DMEM w/o phenol red) containing 5% charcoal stripped
etal bovine serum, 20 mM HEPES, 2 mM  l-glutamine, 100 U/mL
enicillin, 0.1 mg/mL  streptomycin, and 2.5 g/mL amphotericin B
as used. After one day allowing the cells to attach, the cell cul-
ure medium was replaced with 100 L medium containing the
dequate controls (blank, negative/solvent/positive control) and
he sample extracts in eight replicates each. 17-Estradiol was
sed as positive control in concentrations ranging from 10 nM
o 1 fM.  Sample extracts (in DMSO) were diluted 200-fold (opti-
ization experiments) or 400-fold (optimized procedure) with
edium, resulting in a ﬁnal solvent concentration of 0.5% or 0.25%
v/v). In these concentrations, DMSO did not exhibit any effects
ompared to untreated controls. After ﬁve days of incubation,
roliferation was determined using resazurin (Alamar Blue) as a
arker for metabolic activity [24,25]. For that, a stock solution
f 0.1 mg/mL  resazurin sodium salt (CAS 62758-13-8) was pre-
ared in PBS (w/o Ca2+/Mg2+) and ﬁltered sterile. 30 L of resazurin
olution were added to each well. After incubation over night
bsorbance was measured photometrically at 595 nm and 540 nm
avelength.
.7. Data analysis
In  the E-Screen, the percentage reduction of resazurin is pro-
ortional to the cell number and was calculated according to AbD
erotec [26] for all controls and samples. In each experiment a dose
esponse curve for 17-estradiol (positive control) was generated
sing a four-parameter logistic function. The percentage reduction
f resazurin was normalized to the solvent control (0%) and the
aximal response induced by 17-estradiol (100%). This provides
o-called relative proliferative effects (RPE) as described by Soto
t al. [22]. Here, the presented RPE refer to the estrogenic effect of
he water extracts in the experiments, not the original water sam-
les. Since the water samples were concentrated by factor 15,000
r 30,000 via SPE and diluted in the E-Screen 200- or 400-fold, the
nal concentration factor was 75 for all samples. Accordingly, the
PE reported here refer to a volume of 100 L per well and are
herefore equivalent to a sample volume of 7.5 mL  of the respective
ater sample.
In  addition to the RPE, estradiol equivalents (EEQ) were cal-
ulated by non-linear interpolation from dose response curve of
7-estradiol in the respective experiment as described by Wagner
nd Oehlmann [17]. Derived EEQ were corrected for the concen-
ration factor of 75 and reported as pg/L of the original water
ample. The limit of quantiﬁcation calculated from the mean effect
f the solvent control plus three times the standard error was
3.6 pg EEQ/L for the E-Screen and 0.45 pg EEQ/L for the sample
xtracts accordingly.
Data  analysis was performed using GraphPad Prism 5.03
GraphPad Software Inc., San Diego, CA). Nonparametric
ruskal–Wallis tests (with Dunn’s multiple comparison test)
ere applied to compare the medians of data sets. For pair-wise
omparison of bottled water from glass and PET bottles we
sed nonparametric Mann–Whitney tests. A p value of <0.05water  extracted without evaporation (method B) compared to evaporated extracts
(method A) and the solvent control (SC, p < 0.01).
was  regarded as signiﬁcant. All presented data comprise of
mean ± standard error of the mean (SEM).
3.  Results
3.1. Effect of sample evaporation on the estrogenic activity
The  aim of the ﬁrst set of experiments was to determine if spe-
ciﬁc steps of sample preparation lead to a loss of estrogenicity.
Therefore, the common procedure of drying of SPE columns after
extraction and the complete evaporation of sample extracts there-
after (method A) was  compared to a procedure that minimized
these evaporation steps (method B). The results of this compar-
ison indicate that tap water as procedural blank did not induce
signiﬁcant estrogenic effects in the E-Screen, irrespective of the
sample treatment procedure (Fig. 1). Extraction of bottled water
(sample 18) according to method A (complete evaporation of the
extracts) resulted in an increased but not statistically signiﬁcant
estrogenic response in the E-Screen (15.4 ± 6.58% RPE). Compared
to that, extraction of the same bottled water according to method
B (including DMSO as keeper) yielded extracts with a pronounced
and statistically signiﬁcant estrogenic activity (62.8 ± 12.5% RPE).
In case of bottled water, the difference between the two  sample
preparation procedures is statistically signiﬁcant (p = 0.008).
3.2. Comparison of the extraction efﬁcacy of different SPE
methods
To  determine the extraction efﬁcacy for estrogenic activity from
bottled water we  compared six different SPE sorbents. The extrac-
tion was performed according to method B from the previous
experiments because a sample preparation that minimizes the
evaporation of volatile compounds proved to be suitable. In case
of all extractions, neither the used solvents and the extracts from
empty SPE cartridges, nor the procedural blanks (extracted tap
water) contained signiﬁcant estrogenic activity (data not shown).
This indicates that the extraction procedure itself did not result in
an estrogenic contamination of the samples.
M.  Wagner, J. Oehlmann / Journal of Steroid Biochemistry & Molecular Biology 127 (2011) 128– 135 131
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Fig. 4. Inﬂuence of the packaging material on the estrogenic activity of bottled
water.  Pooled analysis of products from the same springs bottled either in glassig. 2. Efﬁcacy of different SPE methods to extract estrogenic activity from bottled
ater.  From all sorbents (C18, Carb, ENV+, HLB, SDB1, SDBXC), only C18 extracted
igniﬁcant  levels of estrogenicity compared to the solvent control (SC, p < 0.001).
SPE sorbents on the basis of styrene-divinylbenzene (SDB1 and
DBXC) and hydroxylated styrene-divinylbenzene (ENV+) did not
xtract signiﬁcant estrogenic activity from bottled water (Fig. 2).
he same hold true for sorbents consisting of an amorphous car-
on molecular sieve (Carb) or a N-vinylpyrrolidone-divinylbenzene
opolymer (HLB). Compared to that, the C18 sorbent yielded an
xtract of the same bottled water that was signiﬁcantly estrogenic
n the E-Screen (97.1 ± 14.8% RPE, p < 0.0001). Taken together, the
PE method employing a traditional silica-based sorbent (C18) and
 sample preparation that minimizes evaporation steps is the most
ffective for the extraction of estrogen-like compounds from bot-
led water.
.3.  Estrogenic activity of bottled water
Based on the previous experiments, we applied the optimized
ample preparation procedure to 18 different products of bottled
ater. In the E-Screen, 11 of the 18 extracted bottled waters (61.1%)
nduced a signiﬁcant estrogenic response (Fig. 3, pooled data from
hree independent experiments). In these samples relative pro-
iferative effects ranged from 19.8 (sample 12) to 50.2% (sample
7) of the maximal effect induced by 17-estradiol (pooled data
ig. 3. Estrogenic activity of different bottled water products (samples 1–18) in the
-Screen. The ﬁrst ﬁve pairs of samples each originate from the same springs and
re bottled in glass and plastic (PET). Signiﬁcant differences compared to the solvent
ontrol (SC, p < 0.01, p < 0.001).(sample 1, 3, 5, 7, 9) or plastic (PET, samples 2, 4, 6, 8, 10). Water bottled in PET con-
tains signiﬁcantly higher estrogenicity compared to water from glass (p < 0.001).
Signiﬁcant  differences compared to the solvent control (SC, p < 0.05, p < 0.001).
from three independent experiments). In four samples of bottled
water (products 1, 2, 4, and 9) we  did not detect any proliferative
effects compared to the appropriate solvent controls, indicating the
absence of estrogen-like chemicals in these extracts. Extracts of
three other products (3, 11, and 15) induced an elevated prolif-
eration of MCF7 cells (RPE: 9.17–12.1%) that was statistically not
signiﬁcant.
The relative proliferative effect provides information on the
effect of the sample extract in the E-Screen (equivalent to 7.5 mL
of bottled water). To quantify the estrogenic activity of the orig-
inal water samples we  derived estradiol equivalents (EEQ) that
are related to 1 L of bottled water (Table 1). In samples with
signiﬁcantly elevated estrogenicity these ranged from 1.9 ± 0.25
to 12.2 ± 3.57 pg EEQ/L. The average estrogenic activity of bottled
water calculated from all analyzed samples is 3.33 ± 0.30 pg EEQ/L
(n = 432).
3.4. Inﬂuence of the packaging material on estrogenicity
To investigate the effect of the packaging material on the estro-
genic activity of bottled water, we  included ﬁve pairs of products
in our sample set that were available in glass as well as plastic
(PET) bottles. Each sample pair (1 + 2, 3 + 4, 5 + 6, 7 + 8, 9 + 10) origi-
nated from the same natural spring. This enables the comparison of
the different packaging materials. Water from two bottlers (1 + 2,
3 + 4) did not contain signiﬁcantly elevated levels of estrogenic
activity, irrespective of the packaging material (Fig. 3.). However,
in all other cases, estrogenicity was signiﬁcantly higher in water
from PET bottles compared to the appropriate sample from glass
bottles (5 vs. 6 p = 0.0078, 7 vs. 8 p = 0.0018, 9 vs. 10 p < 0.0001).
Estradiol equivalents calculated for these samples (Table 1) were
63.7–87.2% higher in water from PET vs. glass bottles. A pooled
analysis of these sample pairs is provided in Fig. 4. The average
estrogenic activity of glass-bottled water is 1.48 ± 0.23 pg EEQ/L. In
water from the respective PET bottles, we derived estradiol equiv-
alents of 4.68 ± 0.86 pg EEQ/L. Again, estrogenicity is signiﬁcantly
higher in water from PET material compared to samples from glass
bottles (p = 0.0009).
In water provided in a cardboard beverage carton (sample 14)
we also detected signiﬁcant estrogenic activity in the E-Screen
(2.96 ± 0.46 pg EEQ/L). For this kind of packaging, a comparison to
132 M.  Wagner, J. Oehlmann / Journal of Steroid Biochemistry & Molecular Biology 127 (2011) 128– 135
Table 1
Estrogenic activity of bottled water in the E-Screen (data from three independent experiments).
Sample Packaging Estrogenic activity (mean ± SEM)
Material Volume Type RPE (%) EEQ (pg/L) n
1 Glass 0.7 L Reusable b.d.l.a b.d.l. 24
2  PET 1 L Single-use b.d.l. b.d.l. 24
3  Glass 0.7 L Reusable 10.8 (4.52) 1.64 (0.39) 24
4 PET 1  L Reusable b.d.l.  b.d.l. 24
5 Glass  0.75 L Reusable 21.9 (4.14) 2.12 (0.49) 24
6  PET 1 L Reusable 39.2 (4.61) 5.84 (1.15) 24
7  Glass 0.75 L Reusable 25.2 (4.57) 2.94 (0.85) 24
8  PET 1 L Single-use 48.5 (4.84) 12.2 (3.57) 24
9  Glass 1 L Reusable 0.88 (4.20) 0.62 (0.21) 24
10 PET 1.5  L Single-use 36.4 (4.54) 4.86 (0.82) 24
11 PET 1.5  L Single-use 12.1 (3.98) 1.18 (0.25) 24
12  PET 1 L Reusable 19.8 (3.45) 1.90 (0.25) 24
13 PET  1.5 L Single-use 34.0 (3.32) 4.20 (0.68) 24
14  Carton 1 L Single-use 27.5 (3.94) 2.96 (0.46) 24
15  PET 1.5 L Single-use 9.17 (2.98) 0.96 (0.19) 24
16  PET 1.5 L Single-use 31.1 (4.36) 4.24 (0.92) 24
17  PET 1.5 L Single-use 50.2 (4.60) 11.3 (1.97) 24
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a b.d.l., below detection limit.
ther materials is difﬁcult because these products are rarely avail-
ble in glass bottles.
.  Discussion
.1. Sample preparation for bioassays: what you extract is what
ou  see
Preparation techniques for water sample are commonly opti-
ized for the enrichment and analytical determination of one
peciﬁc compound. Here, we employed an optimization strat-
gy to adapt traditional solid phase extraction methodology for
he isolation of estrogenic activity from bottled water. In con-
rast to chemical analysis, the target compound(s) responsible for
he biological effects detected in bioassays are often unknown.
n this case, an optimization of sample preparation therefore
elies on maximizing the biological effect observed in the bioas-
ay.
For estrogen-like compounds from bottled water our data
emonstrate that evaporation steps during the sample prepara-
ion lead to a considerable loss of estrogenicity. This observation
s in accordance with results from a previous study: Boehmler et al.
27] detected estrogenic activity in extracts of one brand of min-
ral water in the E-Screen (25.7% RPE) when DMSO was  used as
eeper. When the same extract was evaporated to dryness with-
ut DMSO, the estrogenic activity considerably decreased to 9.5%
PE. From these ﬁndings we can conclude that the estrogen-like
ompound(s) in bottled water are volatile and may  be lost during
ample evaporation.
The  comparison of different methods of solid phase extrac-
ion furthermore indicates that the choice of sorbent determines
he effect detected in the bioassay. This is due to the selective
nrichment of bioactive compounds by the different sorbents.
PE matrices based on copolymers or carbon spheres are often
egarded as “gold standard” for the extraction of organic com-
ounds from aqueous samples. In case of bottled water, these
orbents are less effective in extracting estrogenicity compared
o a traditional silica based matrix (C18). This might be due to
n insufﬁcient retention of estrogen-like compounds or an addi-
ional enrichment of anti-estrogenic substances. The latter holds
rue for a sorbent based on hydroxylated styrene-divinylbenzene
ENV+): bottled water extracts yielded with this type of SPE col-
mn do not induce estrogenic effects in the E-Screen but containuse 24.9 (4.00) 2.49 (0.51) 24
potent  anti-estrogenic activity in a yeast-based bioassay that might
mask potential estrogenic effects (unpublished data). On the one
hand, this demonstrates that a complex mixture of diverse-acting
endocrine disruptors is present in bottled water. On the other hand
these ﬁndings also reveal the limitations of commonly employed
sample extraction techniques. A speciﬁc sorbent is able to extract
only a ﬁnite fraction of the broad spectrum of bioactive compounds
from a complex sample. In case of bottled water the C18 sorbent
retains estrogenicity more effectively compared to sorbents that
are selective for polar chemicals. This indicates that this method is
preferable to extract estrogen-like compounds from bottled water
and that the respective compounds are more likely to be non-
polar.
Taken together, the application of inappropriate sample prepa-
ration techniques may  lead to false-negative results in bioassays
due to a loss of volatile compounds or an ineffective enrichment of
target compounds during extraction. This demonstrates the need to
develop adapted sample preparation methods when the biological
effect of samples with unknown (mixtures of) bioactive compounds
is characterized in bioassays.
4.2.  Estrogenic activity in bottled water: growing body of
evidence
Employing an optimized sample preparation method, our
results demonstrate a broad contamination of bottled water with
estrogen-like chemicals. Eleven of the 18 investigated products sig-
niﬁcantly induced estrogenic effects in a human cancer cell line
(E-Screen) with proliferative effects from 19.8 to 50.2% compared
to 17-estradiol (1.9–12.2 pg EEQ/L).
In  addition to this study, there are four published reports on
estrogenicity in bottled water emphasizing that its contamination
with endocrine disruptors is more than a singular phenomenon.
Boehmler et al. [19] investigated extracts of 37 German bottled
water products (packed in PET, carton, and glass) in the E-Screen.
With a relative proliferative effect of more than 14% RPE, eight of
37 bottled waters were estrogenic. In a second campaign, Boehm-
ler et al. [19] tested these eight products again and found seven
products to be estrogenic. The RPE of positive samples in the E-
Screen ranged from 16 to 71%. Interestingly and in accordance to
our study, tap water was classiﬁed as estrogen-negative. Though
not published under peer review, the nonproﬁt organization Envi-
ronmental Working Group commissioned a study of bottled water
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rom the United States. Experiments conducted at the University of
issouri provide evidence that extracts of one of ten tested prod-
cts induce a relative proliferative effect of 78% RPE in the E-Screen
28].
With regard to the broad spectrum of products analyzed in the
hree available E-Screen studies, the consistent detection of estro-
enic effects of bottled water is remarkable. Unfortunately, the
eported relative proliferative effects are not suitable for a quanti-
ative comparison because Boehmler et al. [19] and Naidenko et al.
28] did not report in which concentration factor they tested the
espective water extracts. To overcome this shortcoming, we  per-
ormed a reanalysis of Boehmler et al.’s unattributed raw data to
stimate estradiol equivalents according to the method used in
his study. Although Boehmler et al.’s study was originally not
esigned for quantitative analysis, estradiol equivalents of the
ecalculated water samples were in the same range (pg EEQ/L) as
n our study.
Besides these results from human cell culture experiments,
here are two studies that employ a yeast-based bioassay (YES) to
nvestigate estrogenicity in bottled water. Although two  slightly
ifferent yeast strains [29,30] were used in these investigations,
ES systems generally determine estrogenic activity as activation
f the human estrogen receptor alpha.
In our previous work we tested untreated water samples of 20
roducts of bottled water (packed in PET, carton, and glass) and
ound that twelve samples contained signiﬁcantly elevated levels of
strogenic activity [17]. In positive samples, the estrogenic potency
anged from 2.64 to 75.2 ng EEQ/L. Notwithstanding the fact that
ur current sample set comprehends mostly other products than
he previous one, the ratio of samples that are estrogenic in the two
ifferent bioassays is remarkably similar. Approximately 60% of
roducts was tested positive in the YES and the E-Screen. For sam-
les investigated in both studies qualitative results are completely
onsistent for both assays.
In bottled water from Italy (SPE extracts of nine products, all
acked in PET) Pinto and Reali [18] detected 0.9–23.1 ng EEQ/L. The
uthors deﬁned a cut-off value of 10% of the effect of 10 nM 17-
stradiol and accordingly classiﬁed eight of nine products as weakly
strogenic. Compared to the ﬁndings by Wagner and Oehlmann
17], the low activity reported by Pinto and Reali [18] is some-
hat surprising. It might be attributed to the lack of sensitivity of
he used bioassay as pointed out by Sax [31] or the loss of volatile
strogen-like compounds during sample preparation as discussed
reviously. Apart of these negligible quantitative differences, Pinto
nd Reali’s study adds up to the growing body of literature demon-
trating the broad contamination of bottled water with endocrine
isruptors.
Compared to the data from E-Screen, the higher estrogenic activ-
ty of bottled water in the YES is unexpected, since the E-Screen
s a more sensitive tool for detecting estrogenicity (in case of our
tudies by a factor 50). The potent estrogenic activity we deter-
ined in untreated bottled water in the YES [17] gives rise to
he assumption that only a fraction of estrogen-like compounds
ctually present in bottled water is extractable. Such compound(s)
ight be too polar to be retained by common SPE sorbents. This
emonstrates a fundamental dilemma when monitoring effects of
omplex samples containing unidentiﬁed bioactive compounds:
hatever preparation technique is employed, absolute recovery
f all chemicals present in such samples is simply not achievable.
herefore, only an unknown portion of the sample’s actual toxicity
an be assessed [32]. Bearing this limitations in mind, it is notable
hat studies from four different institutions, performed with two
ifferent bioassays and samples from France, Germany, Italy, and
he United States come to the same conclusion: bottled water
s broadly contaminated with endocrine disrupting, estrogen-like
hemicals.istry & Molecular Biology 127 (2011) 128– 135 133
4.3. Sources of estrogenic contamination
Interestingly, the public debate about the estrogenicity of bot-
tled water did not center around the pure fact that there is a
contamination with endocrine disruptors but the question where
this is originating from. In principle, there are three possible sources
of contamination as discussed previously: the spring itself, the
production process and the packaging material [17]. So far, only
few systematic investigations are available on this issue. Boehmler
et al. [19] analyzed water that was  sampled directly at the spring
of several bottling plants. In the E-Screen approximately half of
these spring waters were classiﬁed as estrogenic (4–62% RPE). This
gives rise to the assumption that mineral water springs itself (and
consequently the aquifer) are contaminated with estrogen-like
chemicals. Given the fact that according to the bottler’s infor-
mation, the products investigated here originate from deep wells
(100–700 m depth), an inﬁltration of organic compounds appears
unlikely. Still, an anthropogenic contamination of ground water is
far from impossible. The widespread introduction of pharmaceuti-
cals and chemicals from personal care products in the environment
(including ground water) has been demonstrated (as reviewed in
Ref. [33]). In this respect and because of the far-reaching conse-
quences for human and environmental exposure, investigating the
potential inﬁltration of endocrine disruptors in the aquifer is imper-
ative.
In our work, we focus on food packaging materials as source
of exposure to endocrine disruptors. Using a yeast-based in vitro
assay, we  conﬁrmed that the estrogenic activity of bottled water
from PET containers was approximately twice as high compared to
products from glass bottles [17]. This raised the hypothesis that the
estrogenicity was  caused by chemicals migrating from the plastic
packaging. To pursue this question, we conducted an in vivo exper-
iment with an estrogen-sensitive molluskan model that was  bred
in water bottles made of glass and PET. The reproductive output of
animals housed in plastic bottles was doubled compared to spec-
imen from control groups and glass water bottles. This provided
evidence for the leaching of endocrine disrupting compounds from
water bottles made from PET.
The present data from E-Screen experiments further support
this hypothesis. When comparing products bottled from the same
spring, water packed in PET exhibits a 60–90% higher estrogenic
activity compared to the respective product in glass bottles. This
difference is especially pronounced for the spring of which sam-
ples 9 and 10 originated. Whereas the water from glass bottles did
not contain any signiﬁcant estrogenic activity, we detected promi-
nent estrogenicity in the same product from plastic bottles. Taken
together, data from three different bioassays indicate that PET bot-
tles are one source of estrogen-like compounds in mineral water.
However, additional migration studies are needed to improve our
understanding of the leaching of bioactive compounds from plastic
packaging. The fact that food contact materials are an existing (but
underestimated) source of endocrine disruptors receives increas-
ing scientiﬁc attention and is discussed in depth in this Special
Issue [Muncke, this issue]. This is more than a hypothetical sce-
nario as Muncke [34] recently documented by compiling a list of
50 known or suspected endocrine disruptors that are authorized
for the use in food contact materials in the European Union and the
United States. In addition to this, the utilization of recycled plas-
tic for food contact materials might be a source of contamination
[31].
The endocrine activity of two  products packed in glass bot-
tles (samples 5 and 7) implies that there are additional sources
of estrogenicity in bottled water. Besides a contamination of the
spring or during the production, the bottles’ closure might con-
tribute to the endocrine activity. In the light of these ﬁndings, it
is probable that there are multiple sources of contamination of
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he ﬁnal product. Since empirical data concerning the spring and
he packaging are available, scientiﬁc focus should be set on the
roduction process as potential source of endocrine disruptors in
ottled water.
The  question where the estrogenic contamination of bottled
ater is coming from is interwoven with the elucidation of the
dentity of respective chemical(s). So far, no substantial progress
as been made concerning this issue. As discussed previously, it is
nrealistic that the estrogenic activity in bottled water is caused by
ne single known endocrine disruptor since the estrogenic potency
f those compounds is too low [17]. This view is supported by Franz
nd Welle [35], who employed a theoretical migration model to cal-
ulate that far too high levels of the nonylphenol or bisphenol A are
ypothetically needed to explain the observed estrogenic effects.
owever, this argument is not feasible to exclude the packaging as
otential source of contamination because it is based on a scenario
hat does not take the complexity of the sample’s chemical com-
osition into account. Given the vast number of so-far unidentiﬁed
hemicals in food and food contact materials (non-intentionally
dded substances, break-down products, etc.) it appears likely that
he effects observed in bottled water are caused by either a mixture
f several weakly estrogenic compounds or an unknown bioactive
ubstance with high estrogenic potency.
.4. Exposure to estrogen-like chemicals from bottled water
From  the available date we can conclude that bottled water is
 source of human exposure to chemicals that mimic  estrogen in
itro. A quantitative evaluation of exposure to estrogenic activity
e.g. as total daily intake of estradiol equivalents) might prove to
e a suitable integrated criterion to include unknown endocrine
isruptors and mixture effects in exposure assessment. Unfortu-
ately, up to date this is hindered by methodological differences in
ample preparation, bioassays, and data analysis. From a qualita-
ive point of view, the steadily increasing consumption of bottled
ater, the high ratio of estrogen-positive products in different stud-
es, and the broad range of samples included therein, leads to the
ssumption that exposure to endocrine disruptors from bottled
ater is a transnational phenomenon. Based on a daily consump-
ion of 1–2 L [18], the total daily intake of estrogenicity from bottled
ater can be estimated to be in a range of picogram to nanogram
stradiol equivalents. This intake could result in a low dose but long
erm exposure to estrogen-like compounds that affects a broader
opulation, including potentially sensitive subpopulations (infants,
regnant women, and women with breast cancer). However, an
ctual assessment of potential effects to human health requires
he identiﬁcation of the chemical(s) responsible for the observed
strogenic effects. In that context, the combination of bioanalyt-
cal and analytical techniques provides a powerful tool to create
 more holistic understanding of the complex human exposure to
ndocrine disruptors.
onﬂict  of interest
The  authors declare to have no conﬂict of interest.
cknowledgments
This study was in part supported by the German Federal Envi-
onment Agency (Research & Development Project 206 67 448/04).
he statements in this paper do not necessarily reﬂect the views of
he sponsor. We  thank Dr. A.M. Soto for kindly providing the MCF7
ell line and Dr. G. Boehmler for the raw data of her study. More-
ver, we appreciate the comments of Dr. J. Bachmann, M. Behr, and
. Jersch that greatly helped to improve this manuscript.
[
[istry & Molecular Biology 127 (2011) 128– 135
References
[1] Wingspread Consensus Statement, Statement from the work session on
chemically-induced alterations in sexual development: the wildlife/human
connection. http://www.ourstolenfuture.org/Consensus/wingspread1.htm,
1991  (accessed 17.08.10).
[2] E. Diamanti-Kandarakis, J.P. Bourguignon, L.C. Giudice, R. Hauser, G.S. Prins,
A.M. Soto, R.T. Zoeller, A.C. Gore, Endocrine-disrupting chemicals: an Endocrine
Society scientiﬁc statement, Endocr. Rev. 30 (4) (2009) 293–342.
[3] H.M. Koch, A.M. Calafat, Human body burdens of chemicals used in plastic
manufacture, Philos. Trans. Roy. Soc. B: Biol. Sci. 364 (1526) (2009) 2063–2078.
[4] L.N. Vandenberg, I. Chahoud, J. Heindel, V. Padmanabhan, F.J.R. Paumgartten,
G. Schoenfelder, Urinary, circulating, and tissue biomonitoring studies indicate
widespread exposure to bisphenol A, Environ. Health Perspect. 118 (8) (2010)
1055–1070.
[5] C.G. Daughton, Non-regulated water contaminants: emerging research, Envi-
ron. Impact Assess. Rev. 24 (7–8) (2004) 711–732.
[6]  A. Kortenkamp, Ten years of mixing cocktails: a review of combination effects
of endocrine-disrupting chemicals, Environ. Health Perspect. 115 (Suppl. 1)
(2007) 98–105.
[7] S. Christiansen, M.  Scholze, M.  Dalgaard, A.M. Vinggaard, M.  Axelstad, A.
Kortenkamp, U. Hass, Synergistic disruption of external male sex organ devel-
opment by a mixture of four antiandrogens, Environ. Health Perspect. 117 (12)
(2009) 1839–1846.
[8] A. Kortenkamp, T. Brackhaus, M.  Faust, State of the art report on
mixture toxicity—ﬁnal report. http://ec.europa.eu/environment/chemicals/
pdf/report Mixture%20toxicity.pdf,  2009 (accessed 17.08.10).
[9] K.O. Klein, J. Baron, M.J. Colli, D.P. McDonnell, G.B. Cutler, Estrogen-levels in
childhood determined by an ultrasensitive recombinant cell bioassay, J. Clin.
Invest. 94 (6) (1994) 2475–2480.
10] A.M. Soto, M.F. Fernandez, M.F. Luizzi, A.S.O. Karasko, C. Sonnenschein, Devel-
oping a marker of exposure to xenoestrogen mixtures in human serum, Environ.
Health Perspect. 105 (1997) 647–654.
11] F. Paris, N. Servant, B. Terouanne, P. Balaguer, J.C. Nicolas, C. Sultan, A new
recombinant cell bioassay for ultrasensitive determination of serum estrogenic
bioactivity in children, J. Clin. Endocrinol. Metab. 87 (2) (2002) 791–797.
12] K.O. Klein, V. Mericq, J.M. Brown-Dawson, K.A. Larmore, P. Cabezas, A. Cortinez,
Estrogen levels in girls with premature thelarche compared with normal pre-
pubertal girls as determined by an ultrasensitive recombinant cell bioassay, J.
Pediatr. 134 (2) (1999) 190–192.
13] F. Paris, C. Jeandel, N. Servant, C. Sultan, Increased serum estrogenic bioactivity
in three male newborns with ambiguous genitalia: a potential consequence of
prenatal exposure to environmental endocrine disruptors, Environ. Res. 100
(1) (2006) 39–43.
14] T. Tsutsumi, Y. Amakura, M.  Nakamura, D.J. Brown, G.C. Clark, K. Sasaki, M. Toy-
oda, T. Maitani, Validation of the CALUX bioassay for the screening of PCDD/Fs
and dioxin-like PCBs in retail ﬁsh, Analyst 128 (5) (2003) 486–492.
15] T. Takamura-Enya, J. Ishihara, S. Tahara, S. Goto, Y. Totsuka, T. Sugimura, K.
Wakabayashi, Analysis of estrogenic activity of foodstuffs and cigarette smoke
condensates using a yeast estrogen screening method, Food Chem. Toxicol. 41
(4) (2003) 543–550.
16] M.L. Scippo, G. Eppe, E. De Pauw, G. Maghuin-Rogister, DR-CALUX(R) screening
of food samples: evaluation of the quantitative approach to measure dioxin,
furans and dioxin-like PCBs, Talanta 63 (5) (2004) 1193–1202.
17] M Wagner, J. Oehlmann, Endocrine disruptors in bottled mineral water: total
estrogenic burden and migration from plastic bottles, Environ. Sci. Pollut. Res.
16 (3) (2009) 278–286.
18] B. Pinto, D. Reali, Screening of estrogen-like activity of mineral water stored in
PET bottles, Int. J. Hyg. Environ. Health 212 (2) (2009) 228–232.
19] G. Boehmler, R. Kohnen, U. Borowski, A. Ruehe, Einsatz eines biologischen Test-
systems (E-Screen) in der amtlichen Lebensmittelüberwachung zum Nachweis
estrogen wirksamer Substanzen, J. Verbr. Lebensm. 1 (2006) 325–331 (in Ger-
man).
20]  W.  Körner, V. Hanf, W.  Schuller, C. Kempter, J. Metzger, H. Hagenmaier, Devel-
opment of a sensitive E-screen assay for quantitative analysis of estrogenic
activity in municipal sewage plant efﬂuents, Sci. Total Environ. 225 (1–2) (1999)
33–48.
21]  A.M. Soto, H. Justicia, J.W. Wray, C. Sonnenschein, Para-nonyl-phenol—an estro-
genic xenobiotic released from modiﬁed polystyrene, Environ. Health Perspect.
92 (1991) 167–173.
22] A.M. Soto, C. Sonnenschein, K.L. Chung, M.F. Fernandez, N. Olea, F.O. Serrano,
The E-Screen assay as a tool to identify estrogens—an update on estro-
genic environmental-pollutants, Environ. Health Perspect. 103 (1995) 113–
122.
23] W. Körner, P. Spengler, U. Bolz, W.  Schuller, V. Hanf, J.W. Metzger, Substances
with estrogenic activity in efﬂuents of sewage treatment plants in southwest-
ern Germany. 2. Biological analysis, Environ. Toxicol. Chem. 20 (10) (2001)
2142–2151.
24]  J.C. Palomino, A. Martin, M.  Camacho, H. Guerra, J. Swings, F. Portaels, Resazurin
microtiter assay plate: simple and inexpensive method for detection of drug
resistance in Mycobacterium tuberculosis, Antimicrob. Agents Chemother. 46
(8) (2002) 2720–2722.
25] J. O’Brien, I. Wilson, T. Orton, F. Pognan, Investigation of the Alamar Blue
(resazurin) ﬂuorescent dye for the assessment of mammalian cell cytotoxicity,
Eur. J. Biochem. 267 (17) (2000) 5421–5426.
26]  AbD Serotec, alamarBlue® , Technical Datasheet, 2008, 11.
chem
[
[
[
[
[
[
[
[
is packaging a relevant source? Sci. Total Environ. 407 (16) (2009) 4549–
4559.M.  Wagner, J. Oehlmann / Journal of Steroid Bio
27] G. Boehmler, U. Borowski, S. Groell, U. Engelhardt, Abschlussbericht zum
Forschungsprojekt, Projektphase II. Untersuchung estrogen wirksamer Sub-
stanzen in Quellwässern., Niedersächsisches Ministerium für den ländlichen
Raum, Ernährung, Landwirtschaft und Verbraucherschutz 56 (2007) (in Ger-
man).
28]  O. Naidenko, L. Nneka, R. Sharp, J. Houlihan, Bottled water quality investigation:
10 major brands, 38 pollutants. http://www.ewg.org/reports/bottledwater,
2008 (accessed 17.08.10).
29] J.W. Liu, D. Picard, Bioactive steroids as contaminants of the common carbon
source galactose, FEMS Microbiol. Lett. 159 (2) (1998) 167–171.30] E.J. Routledge, J.P. Sumpter, Estrogenic activity of surfactants and some of their
degradation products assessed using a recombinant yeast screen, Environ. Tox-
icol. Chem. 15 (3) (1996) 241–248.
31] L. Sax, Polyethylene terephthalate may  yield endocrine disruptors, Environ.
Health Perspect. 118 (4) (2010) 445–448.
[istry & Molecular Biology 127 (2011) 128– 135 135
32] C.G. Daughton, Cradle-to-cradle stewardship of drugs for minimizing their
environmental disposition while promoting human health. I. Rationale for and
avenues toward a green pharmacy, Environ. Health Perspect. 111 (5) (2003)
757–774.
33]  C.G. Daughton, T.A. Ternes, Pharmaceuticals and personal care products in the
environment: agents of subtle change? Environ. Health Perspect. 107 (1999)
907–938.
34] J. Muncke, Exposure to endocrine disrupting compounds via the food chain:35]  R. Franz, F. Welle, Can migration of endocrine disruptors from plastic bottles be
the cause of estrogenic burden recently determined in bottled mineral water?
Dtsch. Lebensm. -Rundsch. 105 (5) (2009) 315–318.
